Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHARTWELL MOLECULAR

  • FDA Approval
  • Aug. 10, 2023, 11:46 UTC
  • 31
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

CIPLA

  • FDA Approval
  • Aug. 10, 2023, 11:46 UTC
  • 35
  • 0 comments

FDA approve ATAZANAVIR SULFATE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Aug. 10, 2023, 11:46 UTC
  • 34
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Aug. 10, 2023, 11:46 UTC
  • 35
  • 0 comments

FDA approve MESALAMINE

Comment Full text

SUPERNUS PHARMS

  • FDA Approval
  • Aug. 09, 2023, 20:12 UTC
  • 33
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

SAGE THERAP

  • FDA Approval
  • Aug. 09, 2023, 15:50 UTC
  • 35
  • 0 comments

FDA approve ZURANOLONE

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 09, 2023, 11:41 UTC
  • 28
  • 0 comments

FDA approve OLANZAPINE

Comment Full text

HIKMA

  • FDA Approval
  • Aug. 09, 2023, 11:41 UTC
  • 29
  • 0 comments

FDA approve BALSALAZIDE DISODIUM

Comment Full text

ALEMBIC

  • FDA Approval
  • Aug. 09, 2023, 11:41 UTC
  • 31
  • 0 comments

FDA approve GUANFACINE HYDROCHLORIDE

Comment Full text

TORRENT

  • FDA Approval
  • Aug. 09, 2023, 11:41 UTC
  • 35
  • 0 comments

FDA approve PENCICLOVIR

Comment Full text
  • Previous
  • 746
  • 747
  • 748
  • 749
  • 750
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250723)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150062)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin